New York State Common Retirement Fund
APRE icon

New York State Common Retirement Fund’s Aprea Therapeutics APRE Stock Holding History

New York State Common Retirement Fund’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3
Closed – – 3334
2021
Q2 		$0 Sell
3
-417
-99% -$38.5K ﹤0.01% 3545
2021
Q1 		$43K Hold
420
– – ﹤0.01% 3238
2020
Q4 		$41K Hold
420
– – ﹤0.01% 3205
2020
Q3 		$202K Hold
420
– – ﹤0.01% 2638
2020
Q2 		$326K Buy
420
+130
+45% +$85.3K ﹤0.01% 2433
2020
Q1 		$202K Hold
290
– – ﹤0.01% 2452
2019
Q4 		$266K Buy
+290
New +$160K ﹤0.01% 2595

Other funds holding APRE

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

New York State Common Retirement Fund's APRE Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of Aprea Therapeutics (APRE) in Q3 2021, closing a stake of 3 shares.

New York State Common Retirement Fund first reported a position in APRE in Q4 2019 and held it in 7 quarters. The position peaked at $326K in Q2 2020. 39 funds tracked by Wall St. Rank hold APRE as of Q3 2021.

  • New York State Common Retirement Fund reported no remaining Aprea Therapeutics position as of Q3 2021 after selling out during the quarter.
  • New York State Common Retirement Fund sold 3 Aprea Therapeutics shares in Q3 2021.
  • New York State Common Retirement Fund first reported a position in Aprea Therapeutics in Q4 2019 and held it in 7 quarters.
  • New York State Common Retirement Fund's Aprea Therapeutics position peaked at $326K in Q2 2020.
  • 39 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.